Analyst
Citizens
Equibles does not estimate personal net worth.
Sylvan Turkian is recorded as Analyst at Citizens. Sylvan Turkian has spoken on 7 earnings calls and 2 other investor events across 7 companies, most recently for Intellia Therapeutics, Inc. on August 6, 2026. Those appearances were for Nuvation Bio Inc. (NUVB), Intellia Therapeutics, Inc. (NTLA), Context Therapeutics Inc. (CNTX), Celcuity Inc. (CELC), Relay Therapeutics, Inc. (RLAY) and 2 other companies. The companies whose calls Sylvan Turkian spoke on are classified in the Healthcare sector.
“Maybe can you talk a little bit about the patient gateway that you're building with HA reframe and kind of is that more to get data points to you for potential data marketing or is that to kind of push your message out around some of these endpoints where one-time treatment could be helpful?”
“I just want to see if you could provide any more details on the one patient that was left to the patient that was previously discussed as ovarian cancer patient that had a 15% reduction in target lesion.”
“I just have a quick question on the discontinuation rates. So your control on the appellate plus sylvestrant, it performs the discontinuation with significantly better than, for example, in the EPIC trial.”
“Yeah, good morning and congrats on this very strong data and thanks for taking my question.”
“I maybe just want to follow up on the intrathecal injection here. So that is not a procedure, right? So that can be done in the outpatient setting versus maybe some of, you know, other routes of administration that may potentially come to the market as well.”
Citizens
Analyst
Transcript header (unverified)
NUVB
Biotechnology · Healthcare
CELC
Biotechnology · Healthcare
EXEL
Biotechnology · Healthcare
